Combate, Jelly S.

HRN: 18-00-12  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/02/2024
METRONIDAZOLE 500MG (TAB)
02/02/2024
02/09/2024
PO
500MG
TID
FDU
Checking Final Appropriateness 

Indication:  Empiric    Type of Infection:  Reproductive Tract    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Intervention



Type of Intervention done:

                    

           


Acceptance: